ArticleOncotarget2017

Correction: HDAC5, a potential therapeutic target and prognostic biomarker, promotes proliferation, invasion and migration in human breast cancer.

Anqi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.